Skip to main
OCUL
OCUL logo

Ocular Therapeutix (OCUL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Ocular Therapeutix (OCUL) Stock

About Ocular Therapeutix (OCUL)

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Market cap$1.51B
Yesterday's volume3.24M
Revenue (TTM)$59.65M
Avg. daily volume2.15M
EBITDA (TTM)-$200.23M
Open$9.19
Price / earnings ratio-8.24x
Yesterday's range$9.04 - $9.6
Debt / equity28.66x
52 week range$5.79 - $11.78
5 year debt / equity83.93x
Beta (LTM)1.47x
Interest coverage-12.65x
Dividend & yield$0.00 (0.00%)
Current ratio10.22x
Ex-dividend date
Next earningsAug 6, 2025
Dividend payable date

Ocular Therapeutix Stock Rating

What analysts recommend for OCUL stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 47%
Buy 47%
Hold 5%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 02, 2025, the market cap for OCUL stock is $1.51B

The current P/E ratio for OCUL stock is -8.24

The 52-week high for OCUL stock is $11.78. The current OCUL stock price $undefined is 100.00% below its 52-week high

The 52-week low for OCUL stock is $5.79. The current OCUL stock price $undefined has increased 100.00% from its 52-week low

No, the OCUL stock does not pay dividends to its shareholders

The target price for OCUL stock is $19.37 based on the average of what a group of analyst think OCUL stock could be worth at a future date. This is not a prediction by Public.com

How to buy OCUL stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in OCUL stock

    Navigate to the Explore page. Then, type OCUL into the search bar. When you see OCUL stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased OCUL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Ocular Therapeutix Stock Earnings

The value each OCUL share was expected to gain vs. the value that each OCUL share actually gained.

Ocular Therapeutix (OCUL) reported Q1 2025 earnings per share (EPS) of -$0.38, missing estimates of -$0.28 by 35.71%. In the same quarter last year, Ocular Therapeutix's earnings per share (EPS) was -$0.28. Ocular Therapeutix is expected to release next earnings on 08/06/2025, with an earnings per share (EPS) estimate of -$0.35.

Buy Ocular Therapeutix (OCUL) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.